Seven-year outcomes of combined treatment of anti-vascular endothelial growth factor with photodynamic therapy for polypoidal choroidal vasculopathy; according to polypoidal lesion regression. This evidence concerns the gene VEGFA and Polypoidal choroidal vasculopathy.